Isolation of Candida species on media with and without added fluconazole reveals high variability in relative growth susceptibility phenotypes

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 8, 1997, Pages 1625-1635

  Schoofs, A ^a   Odds, F C ^b   Colebunders, R ^c   Ieven, M ^a   Wouters, L ^b   Goossens, H ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL DNA;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDIASIS; CONTROLLED STUDY; CULTURE MEDIUM; DNA FINGERPRINTING; FUNGUS GROWTH; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUTH INFECTION; MOUTHWASH; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPECIES DIFFERENCE;

EID: 0030743446     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.8.1625     Document Type: Article

References (23)

1. Anderson, J., T. Srikantha, B. Morrow, S. H. Miyasaki, T. C. White, N. Agabian, J. Schmid, and D. R. Soll. 1993 Characterization and partial nucleotide sequence of the DNA fingerprinting probe Ca3 of Candida albicans. J. Clin. Microbiol. 31:1472-1480.
2. Cartledge, J. D., J. Midgley, and B. G. Gazzard. 1996. Relative growth measurement of Candida species in a single concentration of fluconazole predicts the clinical response to fluconazole in HIV infected patients with oral candidosis. J. Antimicrob. Chemother. 37:275-283.
3. Daikos, G. L., G. G. Jackson, V. T. Lolans, and D. M. Livermore. 1990. Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. J. Infect. Dis. 162:414-420.
4. Dellion, S., L. Improvisi, B. Dupont, and F. Dromer. 1995. Diversity among yeasts isolated from patients with AIDS and oral candidosis: focus on fluconazole susceptibility testing results. J. Mycol. Med. 5:98-101.
5. 32P-based hybridizations. Anal. Biochem. 210:235-244.
6. Galgiani, J. N., M. S. Bartlett, M. A. Ghannoum, A. Espinel-Ingroff, M. V. Lancaster, F. C. Odds, M. A. Pfaller, J. H. Rex, and M. G. Rinaldi. 1995. Reference method for broth dilution antifungal susceptibility testing of yeasts. Tentative standard. National Committee for Clinical Laboratory Standards, Villanova, Pa.
7. Johnson, E. M., D. W. Warnock, J. Luker, S. R. Porter, and C. Scully. 1995. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J. Antimicrob. Chemother. 35:103-114.
8. Karlowsy, J. A., M. H. Saunders, G. A. J. Harding, D. J. Hoban, and G. G. Zhanel. 1996. In vitro characterization of aminoglycoside adaptive resistance to Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 40:1387-1393.
9. Le Guennec, R., J. Reynes, M. Mallié, C. Pujol, F. Janbon, and J.-M. Bastide. 1995. Fluconazole-and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities. J. Clin. Microbiol. 33:2732-2737.
10. Lockhart, S. R., J. J. Fritch, A. S. Meier, K. Schröppel, T. Srikantha, R. Galask, and D. R. Soll. 1995. Colonizing populations of Candida albicans are clonal in origin but undergo microevolution through C1 fragment reorganization as demonstrated by DNA fingerprinting and C1 sequencing. J. Clin. Microbiol. 33:1501-1509.
11. Louwagie, B., I. Surmont, J. Verhaegen, and F. Odds. 1995. Differential and enrichment media for selective culture and recognition of yeast species from clinical material. Eur. J. Clin. Microbiol. Infect. Dis. 14:406-411.
12. Odds, F. C. 1991. Quantitative microculture system with standardized inocula for strain typing, susceptibility testing, and other physiologic measurements with Candida albicans and other yeasts. J. Clin. Microbiol. 20:2735-2740.
13. Odds, F. C. 1992. Relative growth of Candida species at single antifungal concentrations: a new approach to antifungal susceptibility testing. Antimicrob. Agents Chemother. 36:1727-1737.
14. Odds, F. C., G. Dams, G. Just, and P. Lewi. 1996. Susceptibilities of Candida spp. to antifungal agents visualized by two-dimensional scatterplots of relative growth. Antimicrob. Agents Chemother. 40:588-594.
15. Odds, F. C., L. Vranckx, and F. Woestenborghs. 1995. Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation. Antimicrob. Agents Chemother. 39:2051-2060.
16. Patterson, T. F., S. G. Revankar, W. R. Kirkpatrick, O. Dib, A. W. Fothergill, S. W. Redding, D. E. Sutton, and M. G. Rinaldi. 1996. Simple method for detecting fluconazole-resistant yeasts with chromogenic agar. J. Clin. Microbiol. 34:1794-1797.
17. Scherer, S., and D. A. Stevens. 1988. A Candida albicans dispersed, repeated gene family and its epidemiologic applications. Proc. Natl. Acad. Sci. USA 85:1452-1456.
18. Schmid, J., E. Voss, and D. R. Soll. 1990. Computer assisted methods for assessing strain relatedness in Candida albicans by fingerprinting with the moderately repetitive sequence Ca3. J. Clin. Microbiol. 28:1236-1243.
19. 18a. Schoofs, A. G., F. C. Odds, R. Colebundes, M. Ieven, and H. Goossens. Cross-section study of oral Candida carriage in HIV-seropositive population: predisposing factors, epidemiology and antifungal susceptibility. Submitted for publication.
20. Schoofs, A., F. C. Odds, R. Colebunders, M. Ieven, and H. Goossens. Recognition and identification of Candida dubliniensis isolates from HIV-in-fected patients: use of specialized isolation media. Eur. J. Clin. Microbiol. Epidemiol., in press.
21. Schröppel, K., M. Rotman, R. Galask, K. Mac, and D. R. Soll. 1994. Evolution and replacement of Candida albicans strains during recurrent vaginitis demonstrated by DNA fingerprinting. J. Clin. Microbiol. 32:2646-2654.
22. Soll, D. R. 1992. High-frequency switching in Candida albicans. Clin. Microbiol. Rev. 5:182-203.
23. Soll, D. R. 1996. The emerging molecular biology of switching in Candida albicans. ASM News 62:415-420.